Press release
COVID-19 Therapeutics Market Driven by Strong Pipeline Developments and Adoption of Antivirals and Monoclonal Antibodies
COVID-19 Therapeutics Market
Global COVID-19 Therapeutics Market is expected to grow at a 15.0% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1184
The COVID-19 pandemic triggered a sharp surge in clinical trials aimed at identifying effective therapies to combat the virus. However, since reaching a peak in April 2020, the number of therapeutic-based clinical trials has gradually declined. This trend is attributed to the suboptimal outcomes from several therapeutic trials and the subsequent availability and distribution of vaccines.
Although numerous pharmacological treatments are currently available for both inpatient and outpatient care, only a few have received full regulatory approval. A critical consideration in developing COVID-19 treatments is their efficacy against emerging SARS-CoV-2 variants, as therapies effective against one variant may prove ineffective or less effective against another.
Key factors driving the growth of the COVID-19 therapeutics market include the rapid adoption of newly approved treatment products, increasing healthcare expenditure, heightened public awareness about the virus, and intensified efforts by pharmaceutical companies to develop novel therapeutic solutions.
Ongoing research and innovation continue to advance the field, as evidenced by the World Health Organization's strong 2022 endorsement of nirmatrelvir and ritonavir (commercially known as Paxlovid) for high-risk patients with mild to moderate COVID-19-deeming it the most effective treatment available for this demographic.
Nevertheless, the market faces several challenges. High research and development costs, limited access to advanced healthcare infrastructure in developing economies, and delays in regulatory approvals by bodies such as the FDA and the European Medicines Agency have impeded market growth. Furthermore, financial constraints and concerns regarding the side effects of certain therapeutic products have also acted as deterrents.
North America is expected to maintain the largest share of the global COVID-19 therapeutics market due to the presence of leading pharmaceutical companies and robust research initiatives. Continued governmental investments, collaborations between manufacturers and research institutions, and dedicated funding for treatment development are anticipated to support sustained market expansion in the region.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Significant key Players in COVID-19 therapeutics market are AstraZeneca plc, Celltrion Healthcare Co., Ltd, Pfizer Inc., Ridgeback Biotherapeutics, Merck & Co., Veru Inc., Gilead Sciences, Inc., GSK plc, Shionogi & Company, Limited, NRx Pharmaceuticals, Inc., Kintor Pharma-B, Regeneron Pharmaceuticals, CytoDyn, Atea Pharmaceuticals, Inc., Amarin Corporation, APEIRON Biologics AG, Abivax SA, Alexion Pharmaceuticals, Bellerophon Therapeutics, Blade Therapeutics, Inc, Roivant Sciences, Synairgen, Sorrento Therapeutics, Fulcrum Therapeutics, Ono Pharmaceutical Co., Ltd., Revive Therapeutics Ltd. and Other Prominent Players.
Key Market Development
• In Sept 2022, The EU authorized Evusheld, a combination of long-acting antibodies developed by AstraZeneca, as a COVID-19 therapy. The European Commission granted approval based on the findings of the TACKLE Phase III COVID-19 treatment trial, which demonstrated that a single intramuscular (IM) dose of Evusheld provided clinically and statistically significant protection against progression to severe COVID-19 or death from any cause, compared to placebo.
• In May 2022, FDA Approved OLUMIANT® (baricitinib) by Lilly and Incyte for the Treatment of Certain Hospitalized Patients with COVID-19. OLUMIANT is the first & only JAK inhibitor approved by the FDA for treating COVID-19 in hospitalized people requiring varying degrees of oxygen assistance.
• In Dec 2021, Molnupiravir from Merck and Ridgeback is approved for treating high-risk adults with mild to moderate COVID-19. The approval is based on the Phase 3 MOVe-OUT trial, which examined molnupiravir 800 mg twice-daily in non-hospitalized adult patients with unvaccinated SARS-CoV-2 infection, symptom start within 5 days of study randomization, and at least one risk factor related with poor illness outcomes (e.g., heart disease, diabetes).
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1184
Market Segmentation
Global COVID-19 Therapeutics Market, by Drug Class, 2022-2030 (Value US$ Mn)
• Corticosteroids
o Dexamethasone
o Hydrocortisone
o Methylprednisolone
o Others (Prednisone, Others)
• Anti-viral
o Remdesivir
o Nirmatrelvir
o Others (Ivermectin, Others)
• Monoclonal Antibodies
o Sotrovimab
o Casirivimab plus imdevimab
o Others (Bamlanivimab plus etesevimab, Tixagevimab plus, cilgavimab, others)
• Kinase Inhibitors
o Baricitinib
o Others (Tofacitinib, Others)
• Others (anti-inflammatory drugs, convalescent plasma, others)
Global COVID-19 Therapeutics Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America COVID-19 Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe COVID-19 Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific COVID-19 Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America COVID-19 Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa COVID-19 Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Read Overview Report- https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COVID-19 Therapeutics Market Driven by Strong Pipeline Developments and Adoption of Antivirals and Monoclonal Antibodies here
News-ID: 4111758 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Health All In One Machine Market Exclusive Report on Current Trends and Future I …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Health All In One Machine Market Size, Share & Trends Analysis Report By Product Type (Portable health all-in-one machines, Stationary health all-in-one machines), By End User (Hospitals and clinics, Fitness centers and gyms, Homecare settings, Other healthcare facilities), By Distribution Channel (Online retailers, Offline retailers, Direct sales)), Region, Market Outlook And Industry Analysis 2034"
The Global…
Livestock Insurance Market Study Analysis with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Livestock Insurance Market Size, Share & Trends Analysis Report By Coverage (Mortality, Revenue), By Animal Type (Bovine, Swine, Sheep & Goats, Poultry), By Distribution Channel (Direct, Agency/Broker, Bancassurance), Region, Market Outlook And Industry Analysis 2031"
The global livestock insurance market is estimated to reach over USD 8.1 billion by 2034, exhibiting a CAGR of 8.6%during the…
Foreign Exchange Services Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Foreign Exchange Services Market Size, Share & Trends Analysis Report By Services (Currency Exchange, Remittance Services, Foreign Currency Accounts, Others), by Providers (Banks, Money Transfer Operators, Others), by Application (Businesses, Individuals)- Market Outlook And Industry Analysis 2031"
The global Foreign Exchange Services market is estimated to reach over USD 18.27 billion by 2031, exhibiting a CAGR…
DNA Synthesizer Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global DNA Synthesizer Market Size, Share & Trends Analysis Report By type (benchtop DNA synthesizers and large-scale DNA synthesizers), application (drug discovery & development, genetic engineering, and clinical diagnostics) and end users (academic & research institutes, pharmaceutical & biotechnology companies and clinical laboratories.), Region, Market Outlook And Industry Analysis 2034"
The global DNA synthesizer market is estimated…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
